These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 4757219

  • 1. Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose.
    Collste P, Karlsson E.
    Acta Med Scand; 1973 Nov; 194(5):405-11. PubMed ID: 4757219
    [No Abstract] [Full Text] [Related]

  • 2. Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
    Karlsson E.
    Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term use of procaine amide following acute myocardial infarction.
    Kosowsky BD, Taylor J, Lown B, Ritchie RF.
    Circulation; 1973 Jun; 47(6):1204-10. PubMed ID: 4122729
    [No Abstract] [Full Text] [Related]

  • 5. Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure.
    Giardina EG, Heissenbuttel RH, Bigger JT.
    Ann Intern Med; 1973 Feb; 78(2):183-93. PubMed ID: 4683748
    [No Abstract] [Full Text] [Related]

  • 6. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
    Bliddal J.
    Ugeskr Laeger; 1976 Sep 27; 138(40):2425-33. PubMed ID: 968996
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of ventricular arrhythmias after acute myocardial infarct with procaine amide and mexiletine].
    Dolder M, Campbell RW, Talbot RG, Murray A, Prescott LE, Julian DG.
    Adv Clin Pharmacol; 1978 Sep 27; 16():59-70. PubMed ID: 356554
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].
    Henningsen P, Laursen HB, Christiansen BD, Moller J.
    Ugeskr Laeger; 1976 Sep 27; 138(40):2433-7. PubMed ID: 968997
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Procainamide in plasma following administration of sustained-release tablets in acute myocardial infarction.
    Ihlen H, Skomedal T, Stafsnes H, Ditlefsen EM.
    Curr Ther Res Clin Exp; 1975 Mar 27; 17(3):257-62. PubMed ID: 805020
    [No Abstract] [Full Text] [Related]

  • 13. Procaine amide against re-entrant ventricular arrhythmias. Lengthening R-V intervals of coupled ventricular premature depolarization as an insight into the mechanism of action of procaine amide.
    Giardina EG, Bigger JT.
    Circulation; 1973 Nov 27; 48(5):959-70. PubMed ID: 4270892
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Control of procainamide therapy after cardiac infarction.
    Royds R, Shaw TR, Kumana CR, Padgham D, Hamer J.
    Br Heart J; 1973 Aug 27; 35(8):862-3. PubMed ID: 4729848
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Procainamide and phenytoin. Comparative study of their antiarrhythmic effects at apparent therapeutic plasma levels.
    Karlsson E.
    Br Heart J; 1975 Jul 27; 37(7):731-40. PubMed ID: 1098684
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.